Oscar Health, Inc. (NYSE:OSCR) Shares Bought by Virtu Financial LLC

Key Points

• Virtu Financial LLC increased its shares in Oscar Health by 246.7%, purchasing an additional 25,644 shares, bringing its total to 36,037 shares valued at approximately $472,000.
• Oscar Health reported a quarterly revenue of $2.86 billion, showing a 29.0% year-over-year increase, despite posting an EPS of (-$0.89) which beat analysts' expectations.
• Research analysts issued mixed ratings on Oscar Health, with several lowering their price targets, leading to an average target of $12.21, reflecting a generally negative outlook on the stock.

Virtu Financial LLC increased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 246.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,037 shares of the company's stock after acquiring an additional 25,644 shares during the period. Virtu Financial LLC's holdings in Oscar Health were worth $472,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of OSCR. Larson Financial Group LLC lifted its stake in shares of Oscar Health by 83,733.3% in the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after buying an additional 2,512 shares in the last quarter. CWM LLC lifted its stake in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after buying an additional 1,078 shares in the last quarter. Princeton Global Asset Management LLC bought a new position in shares of Oscar Health in the first quarter worth approximately $59,000. GAMMA Investing LLC lifted its stake in shares of Oscar Health by 2,156.4% in the first quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock worth $85,000 after buying an additional 6,189 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after buying an additional 4,185 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Barclays decreased their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, July 23rd. Piper Sandler reiterated a "neutral" rating and issued a $13.00 price target (down from $14.00) on shares of Oscar Health in a research report on Thursday. Robert W. Baird restated a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Raymond James Financial lowered shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Finally, Baird R W cut shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Six investment analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Reduce" and a consensus target price of $12.07.

Oscar Health Stock Up 6.5%

NYSE OSCR traded up $0.95 during trading on Friday, reaching $15.63. 24,657,100 shares of the company's stock traded hands, compared to its average volume of 28,999,364. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The firm has a market cap of $3.98 billion, a price-to-earnings ratio of -19.30 and a beta of 1.86. The company's 50 day simple moving average is $15.94 and its two-hundred day simple moving average is $14.80. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter in the previous year, the firm earned $0.20 EPS. The company's quarterly revenue was up 29.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.